Literature DB >> 16684650

The biological actions of dehydroepiandrosterone involves multiple receptors.

Stephanie J Webb1, Thomas E Geoghegan, Russell A Prough, Kristy K Michael Miller.   

Abstract

Dehydroepiandrosterone has been thought to have physiological functions other than as an androgen precursor. The previous studies performed have demonstrated a number of biological effects in rodents, such as amelioration of disease in diabetic, chemical carcinogenesis, and obesity models. To date, activation of the peroxisome proliferators activated receptor alpha, pregnane X receptor, and estrogen receptor by DHEA and its metabolites have been demonstrated. Several membrane-associated receptors have also been elucidated leading to additional mechanisms by which DHEA may exert its biological effects. This review will provide an overview of the receptor multiplicity involved in the biological activity of this sterol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16684650      PMCID: PMC2423429          DOI: 10.1080/03602530600569877

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  121 in total

1.  Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver.

Authors:  N Delesque-Touchard; S H Park; D J Waxman
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

2.  Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.

Authors:  L B Moore; D J Parks; S A Jones; R K Bledsoe; T G Consler; J B Stimmel; B Goodwin; C Liddle; S G Blanchard; T M Willson; J L Collins; S A Kliewer
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

3.  Estrogen receptor knock-out mice: molecular and endocrine phenotypes.

Authors:  K S Korach
Journal:  J Soc Gynecol Investig       Date:  2000 Jan-Feb

4.  C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways.

Authors:  L J Williams; V Lyons; I MacLeod; V Rajan; G J Darlington; V Poli; J R Seckl; K E Chapman
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 5.  The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

Authors:  A Bayes-Genis; C A Conover; R S Schwartz
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

6.  Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO).

Authors:  S Ogawa; A E Chester; S C Hewitt; V R Walker; J A Gustafsson; O Smithies; K S Korach; D W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

Authors:  A Hermanowski-Vosatka; D Gerhold; S S Mundt; V A Loving; M Lu; Y Chen; A Elbrecht; M Wu; T Doebber; L Kelly; D Milot; Q Guo; P R Wang; M Ippolito; Y S Chao; S D Wright; R Thieringer
Journal:  Biochem Biophys Res Commun       Date:  2000-12-20       Impact factor: 3.575

8.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

Authors:  P M Barger; J M Brandt; T C Leone; C J Weinheimer; D P Kelly
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

9.  Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

Authors:  P A Crossey; J S Jones; J P Miell
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

10.  Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin.

Authors:  M P Playford; D Bicknell; W F Bodmer; V M Macaulay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

View more
  55 in total

1.  The utility and dynamics of salivary sex hormone measurements in the National Social Life, Health, and Aging Project, Wave 2.

Authors:  Michael J Kozloski; L Philip Schumm; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.

Authors:  Dwight R Stickney; Clarence N Ahlem; Elizabeth Morgan; Christopher L Reading; Nanette Onizuka; James M Frincke
Journal:  Am J Transl Res       Date:  2011-04-12       Impact factor: 4.060

3.  DHEA-S inhibits human neutrophil and human airway smooth muscle migration.

Authors:  Cynthia J Koziol-White; Elena A Goncharova; Gaoyuan Cao; Martin Johnson; Vera P Krymskaya; Reynold A Panettieri
Journal:  Biochim Biophys Acta       Date:  2012-07-03

4.  Increased longevity due to sexual activity in mole-rats is associated with transcriptional changes in the HPA stress axis.

Authors:  Steve Hoffmann; Karol Szafranski; Philip Dammann; Arne Sahm; Matthias Platzer; Philipp Koch; Yoshiyuki Henning; Martin Bens; Marco Groth; Hynek Burda; Sabine Begall; Saskia Ting; Moritz Goetz; Paul Van Daele; Magdalena Staniszewska; Jasmin Mona Klose; Pedro Fragoso Costa
Journal:  Elife       Date:  2021-03-16       Impact factor: 8.140

5.  Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.

Authors:  David J Radford; Keqing Wang; Joanne C McNelis; Angela E Taylor; Georg Hechenberger; Johann Hofmann; Hema Chahal; Wiebke Arlt; Janet M Lord
Journal:  Mol Endocrinol       Date:  2010-02-19

6.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice.

Authors:  Nicolas Leuenberger; Sylvain Pradervand; Walter Wahli
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

Review 7.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

8.  Perimenopausal regulation of steroidogenesis in the nonhuman primate.

Authors:  Krystina G Sorwell; Steven G Kohama; Henryk F Urbanski
Journal:  Neurobiol Aging       Date:  2011-06-17       Impact factor: 4.673

9.  Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions.

Authors:  Shaker A Mousa; Christine Gallati; Tessa Simone; Emmy Dier; Murat Yalcin; Evgeny Dyskin; Sudha Thangirala; Christine Hanko; Abdelhadi Rebbaa
Journal:  Aging (Albany NY)       Date:  2009-03-31       Impact factor: 5.682

10.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.